Provectus presents additional data on PV-10 at two separate melanoma conferences

[News]

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced that data and study design features on PV-10 for metastatic melanoma were presented at two separate conferences.

More... (http://www.news-medical.net/news/20110630/Provectus-presents-additional-data-on-PV-10-at-two-separate-melanoma-conferences.aspx)